{
    "organizations": [],
    "uuid": "6b916d06f764b46aae742ede54f9235c46a0d896",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-strides-shasun-to-launch-ranitidin/brief-strides-shasun-to-launch-ranitidine-tablets-in-u-s-idUSFWN1QP0KO",
    "ord_in_thread": 0,
    "title": "BRIEF-Strides Shasun To Launch Ranitidine Tablets In U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Strides Shasun Ltd:\n* STRIDES SHASUN TO LAUNCH RANITIDINE 75MG OTC TABLETS * PRODUCT, TO BE LAUNCHED FOR U.S. MARKETS, WILL BE BACKWARD INTEGRATED AND MANUFACTURED AT JVâ€™S ORAL DOSAGE FACILITY IN CHENNAI Source text: bit.ly/2tp4Yyk Further company coverage:\n ",
    "published": "2018-03-07T21:15:00.000+02:00",
    "crawled": "2018-03-08T17:37:21.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "stride",
        "shasun",
        "ltd",
        "stride",
        "shasun",
        "launch",
        "ranitidine",
        "75mg",
        "otc",
        "tablet",
        "product",
        "launched",
        "market",
        "backward",
        "integrated",
        "manufactured",
        "jv",
        "oral",
        "dosage",
        "facility",
        "chennai",
        "source",
        "text",
        "company",
        "coverage"
    ]
}